DocDollars

Sarepta Therapeutics, Inc.

MA · United States · Reporting entity ID 100000181760

Total reported 2019–2025
$101.5M
#95 of 2,960 reporting companies — 0.1% of all reported industry payments
$13.9M in general payments across 7,090 records, plus $87.6M in research funding across 16,617 records.

How it breaks down

General payments $13,885,636
Research funding $87,569,659

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Sarepta Therapeutics, Inc. reported $101.5M to US doctors and teaching hospitals from 2019 to 2025, ranking #95 of 2,960 reporting companies. 86% of that was research funding and 14% general payments such as consulting, speaking, food and travel. 7,090 general payment records and 16,617 research records were filed.

Common questions about Sarepta Therapeutics, Inc.

How much has Sarepta Therapeutics, Inc. paid US doctors?

Sarepta Therapeutics, Inc. reported $101,455,295 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $13,885,636 in general payments, $87,569,659 in research funding.

How does Sarepta Therapeutics, Inc. rank among drug and device companies?

It ranks #95 of 2,960 reporting entities by total reported value, about 0.1% of all industry payments in the dataset.

Does a payment from Sarepta Therapeutics, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.